Cormedics
Cormedics develops novel technologies that treat the heart with drugs, cells, genes, and device therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
€909k—1m (Dealroom.co estimates Sep 2011.)
Houston Texas (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$750k | Seed | ||
$250k | Seed | ||
| Total Funding | €909k | ||
Recent News about Cormedics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.